首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Critical role of scavenger receptor-BI-expressing bone marrow-derived endothelial progenitor cells in the attenuation of allograft vasculopathy after human apo A-I transfer.
【24h】

Critical role of scavenger receptor-BI-expressing bone marrow-derived endothelial progenitor cells in the attenuation of allograft vasculopathy after human apo A-I transfer.

机译:表达清道夫受体-BI的骨髓内皮祖细胞在人类载脂蛋白A-I转移后同种异体血管病变减轻中的关键作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Allograft vasculopathy is the leading cause of death in patients with heart transplantation. Accelerated endothelial regeneration mediated by enhanced endothelial progenitor cell (EPC) incorporation may attenuate the development of allograft vasculopathy. We investigated the hypothesis that modulation of EPC biology and attenuation of allograft vasculopathy by increased high-density lipoprotein cholesterol after human apo A-I (AdA-I) transfer requires scavenger receptor (SR)-BI expression in bone marrow-derived EPCs. After AdA-I transfer, the number of circulating EPCs increased 2.0-fold (P < .001) at different time points in C57BL/6 mice transplanted with SR-BI(+/+) bone marrow but remained unaltered in mice with SR-BI(-/-) bone marrow. The effect of high-density lipoprotein on EPC migration in vitro requires signaling via SR-BI and extracellular signal-regulated kinases and is dependent on increased nitric oxide (NO) production in EPCs. Human apo A-I transfer 2 weeks before paratopic artery transplantation reduced intimal area at day 21 3.7-fold (P < .001) in mice with SR-BI(+/+) bone marrow but had no effect in mice with SR-BI(-/-) bone marrow. AdA-I transfer potently stimulated EPC incorporation and accelerated endothelial regeneration in chimeric SR-BI(+/+) mice but not in chimeric SR-BI(-/-) mice. In conclusion, human apo A-I transfer accelerates endothelial regeneration mediated via SR-BI expressing bone marrow-derived EPCs, thereby preventing allograft vasculopathy.
机译:同种异体血管病变是心脏移植患者死亡的主要原因。由增强的内皮祖细胞(EPC)整合介导的加速的内皮再生可能会削弱同种异体血管病的发展。我们调查了这样的假设,即在人类载脂蛋白A-I(AdA-I)转移后,通过增加高密度脂蛋白胆固醇来调节EPC生物学并减轻同种异体移植性血管病的衰减,需要在源自骨髓的EPC中进行清除受体(SR)-BI表达。在AdA-I转移后,在SR-BI(+ / +)骨髓移植的C57BL / 6小鼠中,不同时间点的循环EPC数量增加了2.0倍(P <.001),但在SR-BI(+ / +)骨髓中保持不变BI(-/-)骨髓。高密度脂蛋白对体外EPC迁移的影响需要通过SR-BI和细胞外信号调节激酶进行信号传导,并且取决于EPC中一氧化氮(NO)产量的增加。人apo AI转移在腹腔内动脉移植前2周在第21天使SR-BI(+ / +)骨髓小鼠的内膜面积减少了3.7倍(P <.001),但对SR-BI(-)小鼠却没有影响/-)骨髓。 AdA-I转移在嵌合SR-BI(+ / +)小鼠中有效刺激EPC掺入并加速内皮再生,但在嵌合SR-BI(-/-)小鼠中则没有。总之,人类载脂蛋白A-I转移可加速通过表达SR-BI的骨髓来源的EPC介导的内皮再生,从而防止同种异体血管病变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号